BioRestorative Therapies, Inc. BRTX
1.43 USD -0.05 (-3.38%)
Nov 3, 2026, 3:32 PM EST
1.43 Day range 1.53
1.28 52-week range 30.17
- YTD
- +22.22%
- 1 year
- -4.67%
Analyst view
Price target (mean) 13.00 +809.1% upside
Now 1.43
- Target (low)
- 8.00
- Target (mean)
- 13.00
- Target (high)
- 18.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy2
- Buy0
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
- 1 month ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.27 | -0.27 – -0.27 | -0.57 | +52.6% | 475.00K | +2361.1% | 1 |
| Next quarter | -0.26 | -0.26 – -0.26 | -0.5898 | +55.9% | 628.00K | +1694.3% | 1 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 833.00K | +471.3% | 0 |
| Next year | -0.86 | -0.86 – -0.86 | 0.00 | 0.0% | 2.60M | +212.2% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 14, 2024 | Roth MKM | Maintained | Buy | Buy |
| Jun 12, 2024 | Roth MKM | Maintained | Buy | Buy |
| Aug 14, 2023 | Roth MKM | Reiterated | Buy | Buy |
| Dec 7, 2022 | Roth Capital | Initiated | — | Buy |
| Sep 28, 2022 | Maxim Group | Initiated | — | Buy |
| Dec 1, 2021 | Roth Capital | Initiated | — | Buy |